Literature DB >> 31445830

Chinese expert consensus on diagnosis and treatment of infection after fracture fixation.

Nan Jiang1, Bo-Wei Wang1, Yi-Min Chai2, Xin-Bao Wu3, Pei-Fu Tang4, Ying-Ze Zhang5, Bin Yu6.   

Abstract

Currently, accurate diagnosis and successful treatment of infection after fracture fixation (IAFF) still impose great challenges. According to the onset of infection symptoms after implantation, IAFF is classified as early infection (<2 weeks), delayed infection (2∼10 weeks) and late infection (>10 weeks). Confirmation of IAFF should be supported by histopathological tests of intraoperative specimens which confirm infection, cultures from at least two suspected infection sites which reveal the same pathogen, a definite sinus or fistula which connects directly the bone or the implant, and purulent drainage from the wound or presence of pus during surgery. Diagnosis of IAFF is built on comprehensive assessment of medical history, clinical signs and symptoms of the patient, and imaging and laboratory tests. The gold standard of diagnosis is histopathological tests. Treatment of IAFF consists of radical debridement, adequate irrigation, implant handling, systematic and local antibiotics, reconstruction of osseous and/or soft tissue defects, and functional rehabilitation of an affected limb. Early accurate diagnosis and appropriate treatment of IAFF play a key role in increasing the cure rate, reducing infection recurrence and disability risk, restoring limb function and improving quality of life of the patient.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chinese expert consensus; Chronic osteomyelitis; Diagnosis; Fracture-related infections; Treatment

Mesh:

Substances:

Year:  2019        PMID: 31445830     DOI: 10.1016/j.injury.2019.08.002

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  7 in total

1.  A bibliometric analysis of clinical research on fracture-related infection.

Authors:  Cheng Li; Andrew L Foster; Nicholas Hang Bao Han; Andrej Trampuz; Michael Schuetz
Journal:  Biomed Res Int       Date:  2022-04-14       Impact factor: 3.246

2.  Clinical characteristics, treatment, and prognosis of squamous cell carcinoma arising from extremity chronic osteomyelitis: a synthesis analysis of one hundred and seventy six reported cases.

Authors:  Nan Jiang; Su-Yi Li; Ping Zhang; Bin Yu
Journal:  Int Orthop       Date:  2020-07-23       Impact factor: 3.075

3.  Associations between Interleukin Gene Polymorphisms and Risks of Developing Extremity Posttraumatic Osteomyelitis in Chinese Han Population.

Authors:  Nan Jiang; Su-Yi Li; Yun-Fei Ma; Yan-Jun Hu; Qing-Rong Lin; Bin Yu
Journal:  Mediators Inflamm       Date:  2020-05-05       Impact factor: 4.711

4.  Serum Calcium Level Combined with Platelet Count May Be Useful Indicators for Assisted Diagnosis of Extremity Posttraumatic Osteomyelitis: A Comparative Analysis.

Authors:  Guan-Qiao Liu; Nan Jiang; Yan-Jun Hu; Qing-Rong Lin; Lei Wang; Bin Yu
Journal:  Dis Markers       Date:  2021-10-28       Impact factor: 3.434

5.  Vitamin D Receptor Genetic Variations May Associate with the Risk of Developing Late Fracture-Related Infection in the Chinese Han Population.

Authors:  Xing-Qi Zhao; Kun Chen; Hao-Yang Wan; Si-Ying He; Han-Jun Qin; Bin Yu; Nan Jiang
Journal:  J Immunol Res       Date:  2022-02-10       Impact factor: 4.818

6.  Implant surface culture may be a useful adjunct to standard tissue sampling culture for identification of pathogens accounting for fracture-device-related infection: a within-person randomized agreement study of 42 patients.

Authors:  Nan Jiang; Yan-Jun Hu; Qing-Rong Lin; Peng Chen; Hao-Yang Wan; Si-Ying He; Paul Stoodley; Bin Yu
Journal:  Acta Orthop       Date:  2022-09-07       Impact factor: 3.925

7.  Injectable Bacteria-Sensitive Hydrogel Promotes Repair of Infected Fractures via Sustained Release of miRNA Antagonist.

Authors:  Chenyan Yu; Lang Chen; Wu Zhou; Liangcong Hu; Xudong Xie; Ze Lin; Adriana C Panayi; Xingjie Zhan; Ranyang Tao; Bobin Mi; Guohui Liu
Journal:  ACS Appl Mater Interfaces       Date:  2022-07-22       Impact factor: 10.383

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.